AKT1 and non-small cell lung carcinoma: MiR-496 has diminished expression in a wide range of NSCLC cells, and researchers have experimentally demonstrated that overexpression of miR-496 could inactivate the BDNF (a brain-derived neurotrophic factor)-mediated PI3K/Akt signaling pathway to inhibit tumor growth (54).